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Abstract
Background: The present study was carried out to determine whether the p53 pathway played
a role in the spontaneous immortalization of the SC-2 chicken embryo fibroblast (CEF) cell line that
has been in continuous culture for over three years.
Results: The SC-2 cell line emerged from an extended crisis period with a considerably slower
growth rate than primary CEF cells. The phenotype of the SC-2 cells changed dramatically at about
passage 80, appearing smaller than at earlier passages (e.g., passage 43) and possessing a small,
compact morphology. This morphological change coincided with an increase in growth rate.
Passage 43 SC-2 cells expressed undetectable levels of p53 mRNA, but by passage 95, the levels
were elevated compared to primary passage 6 CEF cells and similar to levels in senescent CEF cells.
However, the high level of p53 mRNA detected in passage 95 SC-2 cells did not correlate to
functional protein activity. The expression levels of the p53-regulated p21WAF1  gene were
significantly decreased in all SC-2 passages that were analyzed. Examination of the Rb pathway
revealed that E2F-1 and p15INK4b expression fluctuated with increasing passages, with levels higher
in passage 95 SC-2 cells compared to primary passage 6 CEF cells.
Conclusion: The present study suggests that altered expression of genes involved in the p53 and
Rb pathways, specifically, p53 and p21WAF1, may have contributed to the immortalization of the SC-
2 CEF cell line.
Background
Normal cells cultured in vitro undergo a characteristic
number of divisions before entering a non-dividing state
termed senescence [1]. Most cells are unable to overcome
senescence to continue dividing unless key tumor sup-
pressor pathways are first altered. Cellular immortaliza-
tion has been achieved by the inactivation of the p53 and
Rb pathways or by the activation of telomerase [2,3].
While spontaneous immortalization is an extremely rare
event in human cells [4], rodent cells spontaneously
immortalize at much greater rates [2]. For avian cells,
spontaneous immortalization also has been very rare,
with only two other spontaneously immortalized chicken
cell lines reported (DF-1 [5-8] and SC-1 [9]).
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The tumor suppressor gene, p53, has often been referred
to as the 'cellular gatekeeper' or the 'guardian of the
genome' because of its role in cell cycle arrest and apopto-
sis in response to cellular damage [10,11]. The p53 pro-
tein is dysfunctional in most human cancers, with p53
itself being mutated in about half of these cancers. In the
other half of cancers when p53 itself is not mutated, it is
inactivated indirectly as a result of alterations in the gene
products that interact with p53 or transmit information to
or from p53 [12]. In normal cells, the main negative regu-
lator of p53, MDM2, maintains a relatively short p53 half-
life by targeting it for degradation, thus preventing it from
exerting antiproliferative effects [13]. The MDM2 and p53
proteins operate in a feedback loop whereby MDM2
degrades p53 while p53 activates transcription of MDM2,
thereby helping to maintain low p53 levels in normal cells
[14]. Another important gene involved in the p53 path-
way is ARF, which binds directly to MDM2, protecting p53
from degradation and allowing for the increased expres-
sion of p53 [15,16]. One study showed that senescence
requires an increase in the levels of ARF and that con-
versely, fibroblasts lacking ARF proliferate indefinitely
[17]. Many signals activate p53 such as DNA damage, tel-
omere shortening, hypoxia, and aberrant proliferative sig-
nals. Upon activation, p53 induces a G1/S phase cell cycle
arrest that is mediated by p21WAF1 [18,19], which func-
tions by inhibiting the CDKs (cyclin-dependent kinases)
during the G1 phase of the cell cycle, thereby preventing
cell cycle progression [20-22]. Consistent with this, the
levels of p21WAF1 have been reported to be elevated in
senescent cells [23].
The other main tumor suppressor mechanism involves
the Rb pathway, and alterations in this pathway have been
shown to lead to tumorigenesis [24]. Throughout the cell
cycle Rb undergoes changes in phosphorylation, with a
hyperphosphorylated form predominant in proliferating
cells and a hypophosphorylated form predominant in
quiescent or differentiating cells [25]. As Rb is hyperphos-
phorylated by CDK-cyclins in the mid-to-late G1 phase of
the cell cycle, Rb is unable to bind and inhibit the actions
of E2F-1, allowing E2F-1 to promote cell cycle progression
from the G1 phase of the cell cycle into the S phase [26].
Senescent cells express high levels of the CDK-inhibitor,
p16INK4a, which prevents CDK-cyclins from phosphorylat-
ing Rb, keeping E2F-1 bound to Rb and unable to pro-
mote entry into the S phase of the cell cycle [27,28]. The
p16INK4a gene is inactivated in many tumor cell lines [29-
31], while overexpression of p16INK4a results in G1 arrest
[32].
In the present study, mRNA and protein expression levels
of various genes involved in the p53 and Rb pathways
were measured in multiple passages of a spontaneously
immortalized CEF cell line, SC-2. By analyzing the expres-
sion of important cell cycle regulatory genes at various
stages of the immortalization process it was observed that
the SC-2 cells underwent an initial crisis period between
passages 18 and 33 and another transition period at about
passage 80. From this data, it has been hypothesized that
following the initial crisis period, changes in the expres-
sion of important cell cycle regulatory genes allowed the
cells to continue growing. It is quite possible that addi-
tional coordinated fluctuations in gene expression
allowed the cells to increase their growth rate at approxi-
mately passage 80 and to become fully immortal.
Results and discussion
Growth rate and morphological analysis
In the present study the third reverse transcriptase (RT)-
negative spontaneously immortalized chicken cell line
(SC-2) was established. Data were obtained from many
different passages of SC-2 cells, but only shown for pas-
sages 43 and 95, since they represent the major transition
phases that occurred in the SC-2 cells. An examination of
this type has been performed for another spontaneously
immortalized cell line (SC-1) [9], but the expression of
most cell cycle regulatory genes were very different com-
pared to the SC-2 cells.
The SC-2 cell line was derived from primary CEF cells that
were thawed at passage 4. Between passages 5 and 17 the
growth rate of the CEF cells averaged 1.03 population
doublings per day (pd/d). The cells entered a crisis period
between passages 18 and 33, during which their growth
rate was negligible except for measurable growth between
passages 20 and 21. During this crisis period, cells were
refed every 2–3 days and passaged until small foci of cells
appeared. At about passage 33 a subpopulation of cells
emerged that was able to overcome cellular senescence
and continue growing when other cells in the population
succumbed to cell death. These cells were considered to
have an extended lifespan and as such were designated the
SC-2 cell line. The SC-2 cells continued to grow slowly
between passages 33 and 80 averaging 0.12 pd/d. Passage
43 SC-2 cells were flattened and enlarged compared to the
presenescent CEF cells. The phenotype of the SC-2 cells
changed dramatically at about passage 80, appearing
smaller than observed earlier at passage 43 and possessing
a small, compact morphology, similar to DF-1 cells (Fig.
1A). Coinciding with the dramatic morphological change
at passage 80, the growth rate of the SC-2 cells increased
to an average of 0.60 pd/d after passage 80 (Fig. 1B). The
SC-2 cells are currently at passage 120 and have main-
tained the improved morphology and increased growth
rate since passage 80. The SC-2 cells displayed contact
inhibition when grown to confluence, did not show evi-
dence of multi-layered growth, and did not form colonies
when grown in a semi-solid agarose suspension (data not
shown), suggesting that these cells lacked many of theBMC Cell Biology 2006, 7:27 http://www.biomedcentral.com/1471-2121/7/27
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properties of transformed cells. Karyotypic analysis (data
not shown) of the SC-2 cells indicated that they displayed
a normal diploid karyotype. The SC-2 cells were analyzed
twice for RT activity and mycoplasma contamination and
found to be negative for both (data not shown).
FACS analysis showed that SC-2 cells possessed a distinct
cell cycle distribution compared to either primary passage
6 CEF or immortal DF-1 cells (Fig. 2A). The percentage of
cells in the G1 phase of the cell cycle was 65% for primary
passage 6 CEF cells, 48% for SC-2 cells, and 30% for
immortal passage 280 DF-1 cells.
Cell growth rates were compared as shown in Figure 2B.
Passage 43 SC-2 cells had a very slow growth rate, with
only 0.17 pd/d after six days, while passage 95 SC-2 cells
showed increased growth rates (0.60 pd/d) that where
more similar to primary CEF cells (0.72 pd/d). The DF-1
cells displayed the highest growth rate at 1.33 pd/d after
four days.
Analysis of p53 and p53-regulated genes
Because of the importance the p53 pathway plays in con-
trolling the cell cycle, an examination of p53 and its
related genes was performed during the conversion proc-
ess in the SC-2 cell line using RT-PCR and Southern blot
analysis. Like many other studies, an increase in p53
mRNA expression (25%) was observed in normal senes-
cent passage 18 CEF cells compared to primary passage 6
CEF cells (Fig. 3A). The decreased p53 mRNA expression
in passage 43 SC-2 cells agrees with other studies that have
observed decreased expression of p53 in immortal cells
Morphology and growth curve of primary and immortal CEF cells Figure 1
Morphology and growth curve of primary and immortal CEF cells. A) Representative photomicrographs of primary 
passage 6 CEF cells, senescent passage 18 CEF cells, passage 43 SC-2 cells, passage 95 SC-2 cells and immortal passage 280 DF-
1 cells . B) Growth curve of SC-2 cells. SC-2 cells were plated at a density of 3 × 105 cells/10 cm dish. At 80% confluency cells 
were trypsinized, counted and the number of population doublings per day calculated.
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[8,33]. Unexpectedly, increased p53 levels were observed
in passage 95 SC-2 cells that were similar to levels in
senescent passage 18 CEF cells. One possible explanation
for this observation is the functional inactivation of p53
via deletion or point mutations. However, the nucleotide
sequence of p53 mRNA in the SC-2 cells was identical to
FACS analysis and growth rates of primary and immortal CEF cells Figure 2
FACS analysis and growth rates of primary and immortal CEF cells. A) Cell cycle analysis of pre-senescent passage 6 
CEF, passage 95 SC-2, and immortal passage 280 DF-1 cells was performed using fluorescence-activated cell sorting (FACS) of 
propidium iodide-stained cells. B) To determine growth rates, primary CEF (passage 6) and immortal CEF (passage 43 SC-2, 
passage 95 SC-2, and passage 280 DF-1) cells were plated at a density of 1 × 105 cells/10 cm dish using conditions as described 
in Materials and Methods. Both primary and immortal CEF cells were counted each day for up to 6 days to determine cell num-
bers. The immortal DF-1 cells are only shown through day 4 due to their relatively higher cell numbers.
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Analysis of the p53 pathway using RT-PCR and a p53-Luciferase reporter assay Figure 3
Analysis of the p53 pathway using RT-PCR and a p53-Luciferase reporter assay.A) Relative levels of mRNA expression for 
genes involved in the p53 pathway determined by RT-PCR. For each gene the expression level of passage 6 CEF cells was set 
to 1.0. The levels for other samples were then adjusted accordingly. A minimum of three independent RT-PCR experiments 
were analyzed using the NIH image software program and normalized using the expression levels of GAPDH. Differences 
≤0.05 were considered significant. Different letters indicate significant differences. B) p53 and p21 WAF1 mRNA expression lev-
els were measured by RT-PCR in passage 43 and 95 SC-2 cells as well as in passage 280 DF-1 cells ± the protein synthesis 
inhibitor CHX. C) p53 protein levels in primary passage 6 CEF and passage 95 SC-2. A minimum of three independent West-
ern blot experiments were analyzed using the NIH image software program and normalized using the expression levels of 
actin. Differences ≤ 0.05 were considered significant. D) Altered biological activity of p53 in immortal DF-1 and SC-2 cells using 
the luciferase reporter gene assay. All cells were cotransfected with a control reporter plasmid (Con-Luc) or p53 reporter 
plasmid (p53-Luc) and pcDNA3.1-LacZ plasmid. The β-lactamase (LacZ) gene was amplified by PCR to normalize transfection 
efficiency and the GAPDH gene was amplified by RT-PCR to account for loading differences. Levels of luciferase activity were 
determined using the Luciferase Assay System (Promega) following the manufacturer's instructions. Luciferase activity in the 
cells transfected with the Con-Luc plasmid were set to 1.0. The normalized values shown are relative expression levels with 
s.d. Differences ≤ 0.05 were considered significant. Different letters indicate significant differences.
0.0
0.5
1.0
1.5
2.0
2.5
0.0
0.5
1.0
1.5
2.0
0.0
0.5
1.0
1.5
2.0
0.0
0.5
1.0
1.5
0.0
0.5
1.0
1.5
A
p53
MDM2
p21WAF1
p27Kip1
p57Kip2
GAPDH
P
9
5
 
S
C
-
2
P
6
 
C
E
F
P
1
8
 
C
E
F
P
2
8
0
 
D
F
-
1
P
4
3
 
S
C
-
2
a
b
c
d
b
a a
b
a a
a
b
a
b
c c b
a b
c
d
d
ccd
0
1
2
3
Con-Luc p53-Luc
C
Passage 6 CEF
Passage 95 SC-2 
Passage 280 DF-1
R
e
l
a
t
i
v
e
 
L
u
c
i
f
e
r
a
s
e
 
E
x
p
r
e
s
s
i
o
n
 
L
e
v
e
l
B
CHX - +                     - +                  - +
P280 DF-1 
cells
P43 SC-2 
cells
P 95 SC-2 
cells
p53
p21WAF1
a
b
c
D
P
6
 
C
E
F
 
c
e
l
l
s
P
9
5
 
S
C
-
2
 
c
e
l
l
s
p53
ActinBMC Cell Biology 2006, 7:27 http://www.biomedcentral.com/1471-2121/7/27
Page 6 of 12
(page number not for citation purposes)
that of the published chicken p53 mRNA sequence (Gen-
Bank: X13057) for the first portion of the 5'-end and the
remainder of the 3'-end. We have had difficulties in
sequencing the remaining approximate 250 bp (between
nucleotides 242 and 494), which is predominantly dou-
ble-stranded [34]. With over 80% of the molecule
sequenced, it appears that there are no deletions or muta-
tions that exist. These results suggest that other cellular
modifications may be responsible for the altered activity
of p53 in the SC-2 cells.
To determine whether the fluctuation in p53 mRNA levels
affected other genes involved in the pathway, mRNA
expression levels of MDM2, which is the predominant
negative regulator of p53, were examined. Although the
MDM2 gene is upregulated in 30%-40% of human
tumors [35], the levels of MDM2 in the SC-2 cells were
similar to levels observed in normal primary passage 6
CEF cells. The levels of MDM2 were expected to be higher
in passage 95 SC-2 cells since p53 mRNA levels were ele-
vated. A possible explanation for the unchanged levels of
MDM2 in the present study was that p53 protein was inac-
tive and not able to participate with MDM2 in the normal
feedback loop.
Another important target of p53 is p21WAF1, a gene that
causes arrest at the G1 and G2 phases of the cell cycle. In
order to assess whether or not the fluctuating p53 levels
were functional, mRNA expression of p21WAF1 was meas-
ured. Similar to other studies [36,37], levels of p21WAF1
dramatically increased in senescent passage 18 CEF cells
(82%; Fig. 3A). Significant down-regulation of p21WAF1
mRNA was observed in all passages of SC-2 cells com-
pared to primary passage 6 CEF cells. Since the p21WAF1
gene is up-regulated by p53 in response to DNA damage
[19], the fact that the SC-2 cells possessed extremely low
expression levels of p21WAF1, even in the presence of ele-
vated levels of p53 mRNA, suggested that p53 may be
functionally inactive.
The related gene p27Kip1, which belongs to the same fam-
ily as p21WAF1 (the Kip/Cip family), is a CDK inhibitor
that prevents transition from the G1 to S phase of the cell
cycle. Similar to p21WAF1, levels of p27Kip1 also increased
at senescence in normal CEF cells (45%; Fig. 3A). The lev-
els of p27Kip1 in the immortal DF-1 cells and the SC-2 cells
at passage 43 were slightly elevated. However, by passage
95, levels of p27Kip1 in the SC-2 cells had increased by
almost 40% over levels observed in primary passage 6 CEF
cells.
Another member of the Kip/Cip family is p57Kip2, which
when over-expressed, has been shown to lead to growth
arrest at the G1 phase of the cell cycle in two different cell
lines [38,39]. Conversion of a lifespan extended popula-
tion of human mammary epithelial cells to a fully immor-
tal phenotype was marked by a dramatic decrease in
p57Kip2 expression, indicating that p57Kip2 may be used as
a marker of fully immortal cell lines [40]. Here p57Kip2 lev-
els were slightly increased (11%) in senescent passage 18
CEF cells (Fig. 3A). However, in contrast to others who
have observed decreased expression of p57Kip2 mRNA in
immortal cell lines [41], the SC-2 cells at passages 43 and
95 and the immortal DF-1 cells possessed significantly
increased levels of p57Kip2. While the levels of p57Kip2 in
passage 43 SC-2 cells were increased by 134% over pri-
mary passage 6 CEF cells, the passage 95 SC-2 cells still
possessed levels of p57Kip2 that were 85% greater than the
levels expressed in primary passage 6 CEF cells, but these
levels had decreased considerably from the levels meas-
ured in passage 43 SC-2 cells. This suggested that the SC-
2 cells still may be in the process of converting to a fully
immortal phenotype.
To determine if the altered p53 transcriptional activity in
SC-2 cells was caused by an inhibitory/repressor protein,
cells were treated with the protein synthesis inhibitor,
CHX, which has been shown to stabilize several mRNAs
[42]. It was previously shown that CHX treatment restored
p53 mRNA levels in CEF cells and in immortalized (10)3
and (10)7 murine embryonic fibroblast (MEF) cells
expressing constitutively low levels of p53 mRNA [8]. We
reasoned that a translation inhibitor such as CHX should
block the function of translation-dependent p53 regula-
tory elements that may be present, resulting in increased
p53 mRNA levels. Since primary passage 6 CEF cells pos-
sessed normal levels of p53 mRNA it was not surprising
that CHX had no effect on p53 expression (data not
shown). However, in cells that contained depressed levels
of p53 (passage 43 SC-2 and DF-1 cells), CHX treatment
resulted in an upregulation of p53 mRNA expression (Fig.
3B). This suggested that both the passage 43 SC-2 cells
and DF-1 cells contained a p53-regulatory element that
blocked expression of p53 resulting in a 5- and 2.5-fold
increase in mRNA expression following CHX treatment,
respectively. Removal of this putative p53 inhibitor via
CHX allowed expression levels of p53 mRNA to increase.
However, CHX had no effect in passage 95 SC-2 cells,
which already possessed elevated levels of p53 mRNA
compared to primary passage 6 CEF cells. An examination
of the effect of CHX on the expression of p21WAF1 would
help substantiate the functional status of p53 in the pas-
sage 95 SC-2 cells. However, treatment with CHX had no
effect on the expression of p21WAF1 mRNA expression in
SC-2 cells (Fig. 3B). This indicates that the p53 mRNA lev-
els in passage 95 SC-2 cells and the CHX-restored levels in
passage 43 SC-2 cells were functionally inactive.
Thus far, indirect assessment of the functional activity of
p53 has been demonstrated by measurement of theBMC Cell Biology 2006, 7:27 http://www.biomedcentral.com/1471-2121/7/27
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expression of p53-regulated genes. Since the ability of p53
to activate or repress transcription of downstream genes is
important for cell cycle control, the protein level of p53
and the direct functional activity also were measured.
Unlike the mRNA data that showed an increase in p53
mRNA expression in passage 95 SC-2 cells, Western blot
analysis showed a slightly decreased level of p53 protein
in passage 95 SC-2 cells (Fig. 3C). To determine whether
the protein levels of p53 in the passage 95 SC-2 cells were
functional, direct activity was measured after transfection
of a p53 consensus binding sequence promoter/luciferase
reporter plasmid construct. It was discovered that the
functional protein activity of p53 was 2.8-fold less than
that of primary passage 6 CEF cells (Fig. 3C). The func-
tional inactivation of p53 protein in the passage 95 SC-2
cells likely allowed the cells to escape the growth con-
straints imposed by p53. In the DF-1 cells the functional
p53 activity was greatly decreased compared to the level in
primary passage 6 CEF cells, which is in agreement with
the lower mRNA expression levels observed in the DF-1
cells.
Expression analysis of genes involved in the Rb pathway
Another tumor suppressor that plays a fundamental role
in controlling cell cycle progression and senescence is Rb.
Alterations in this pathway are second only to alterations
in the p53 pathway in human cancers [43]. Surprisingly,
an up-regulation of Rb expression (~40%) was observed
in the SC-2 cells compared to primary passage 6 CEF cells
(Fig. 4A). However, this is in agreement with the results of
a previous study that showed up-regulated levels of Rb
mRNA in the immortal DF-1 cell line [44]. The up-regula-
tion of Rb expression that was observed in all passages of
SC-2 cells examined may be the result of a functionally
inactive p53, as others have shown that Rb mRNA expres-
sion is repressed by p53 in mammalian cells [45].
The tumor suppressor p16INK4a, a key regulator of Rb that
maintains Rb in a hypophosphorylated state, is inacti-
vated in many transformed cell lines [29-31]. Since
p15INK4b assumes the role of p16INK4a in chickens [46], its
mRNA levels were measured. Unexpectedly, only a slight
decrease in p15INK4b expression in passage 43 SC-2 cells
and a significant increase in passage 95 SC-2 cells were
observed. The fact that the passage 95 SC-2 cells possessed
an increased expression of p15INK4b suggested that the Rb
pathway may be altered in the SC-2 cell line. Hypermeth-
ylation of the p15INK4b  promoter in the SC-2 cells is
unlikely since it would result in the downregulation of
p15INK4b mRNA expression, which was not observed in
the SC-2 cells. It is possible that p15INK4b had been inacti-
vated in the SC-2 cells, unlike the DF-1 cells where hyper-
methylation of the p15INK4b gene promoter causes the
downregulation of p15INK4b mRNA expression [59]. To
determine whether the increased levels of p15INK4b mRNA
were translating normal protein levels, Western blot anal-
ysis was used to determine the levels of p15INK4b protein
in the SC-2 cells. As shown in Fig. 4B the p15INK4b protein
levels also were increased (30%) in the SC-2 cells com-
pared to primary passage 6 CEF cells.
The p15INK4b alternate reading frame sequence (ARF), is
encoded by the same genetic locus as p15INK4b, but in a
different reading frame, resulting in two completely differ-
ent genes. The chicken ARF gene was recently isolated, and
it was determined that chicken ARF binds to MDM2 and
stabilizes p53, just as it does in human and mouse [59].
To verify the role of ARF in the immortalization process of
chicken cells, levels were compared in primary and
immortal CEF cells. As predicted, the levels of ARF were
elevated in senescent passage 18 CEF cells and decreased
in passage 43 SC-2 cells (Fig. 4A). Although increased
expression of ARF has been shown to induce cell cycle
arrest [47], this was not observed in the passage 95 SC-2
or DF-1 cells. It has been shown that E2F-1 (an important
gene in the Rb pathway) directly activates the expression
of ARF, establishing a link between the Rb and p53 path-
ways [48]. E2F-1 is one of the growth-regulatory genes
that is suppressed in senescent human cells [49,50] and
can induce senescence when over-expressed in normal
human fibroblasts via ARF. This induced senescence is
dependent upon the presence of a functional p53 gene
[51]. In the present study, elevated levels of E2F-1 were
observed in immortal SC-2 and DF-1 cells, which is simi-
lar to other immortal chicken cell lines developed in our
lab [8]. The study by Bates et al. [48] proposed that induc-
tion of ARF by E2F-1 would stabilize p53 unless there
existed a mutation in ARF or in p53 itself, again support-
ing our hypothesis that p53 was inactive in the SC-2 cells.
Expression analysis of various cell cycle regulatory genes
Since the cell cycle also is regulated by the various cyclins
[43], we examined mRNA expression levels of multiple
chicken cyclin genes (Fig. 5). As expected, decreased
expression for most of the cyclins was observed in senes-
cent passage 18 CEF cells compared to primary passage 6
CEF cells. The only cyclin that was up-regulated was cyclin
D2, which has been shown to increase its expression in
growth-arrested cells [52]. In passage 43 SC-2 cells, the
expression levels of most of the cyclins also were
decreased, except for cyclin B3, which had similar levels
compared to passage 6 CEF cells. However, by passage 95
the expression of cyclins B2, B3 and D1 were increased,
while the expression of cyclins A, C, D2, and E were
decreased compared to primary passage 6 CEF cells.
Although unexpected, the decreased expression of certain
cyclins in the SC-2 cells was also found in the fully immor-
tal DF-1 cells (Fig. 5).BMC Cell Biology 2006, 7:27 http://www.biomedcentral.com/1471-2121/7/27
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Analysis of the Rb pathway Figure 4
Analysis of the Rb pathway. A) Levels of mRNA expression for genes involved in the Rb/p16INK4a pathway measured by RT-
PCR. For each gene, the expression level was set to 1.0 for passage 6 CEF cells. The levels for other samples were then 
adjusted accordingly. A minimum of three independent RT-PCR experiments were analyzed using the NIH image software pro-
gram and normalized using the expression levels of GAPDH. Differences ≤ 0.05 were considered significant. Different letters 
indicate significant differences. B) p15INK4b protein levels in primary passage 6 CEF, and passage 95 SC-2 cells. A minimum of 
three independent Western blot experiments were analyzed using the NIH image software program and normalized using the 
expression levels of actin. Differences ≤ 0.05 were considered significant.
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Levels of mRNA expression for the various cyclins Figure 5
Levels of mRNA expression for the various cyclins. For each gene, the expression level was set to 1.0 for passage 6 CEF 
cells. The levels for other samples were then adjusted accordingly. A minimum of three independent RT-PCR experiments 
were analyzed using the NIH image software program and normalized using the expression levels of GAPDH. Differences ≤ 
0.05 were considered significant. Different letters indicate significant differences.
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Telomere regulation
Telomerase activation has been shown to be an important
step in the immortalization of normal fibroblasts [53].
However, in the current study we were unable to show tel-
omerase activation using the TRAP assay. Previous
attempts to show telomerase activity in other immortal
CEF cells [8,9], including the fully immortal DF-1 cell line
(passage 280) have proven unsuccessful as well. Although
telomerase activity was undetectable in the immortal SC-
2 or DF-1 cells, telomere length did not decrease, even in
senescent passage 18 CEF cells (data not shown). These
results suggested that perhaps alterations in the p53 and/
or Rb pathways may be more important than telomerase
activation for the immortalization of CEF cells, which was
in agreement with our other spontaneously immortalized
cell lines (SC-1 and DF-1). The question still remains as to
how chicken cells maintain telomere length without
detectable telomerase activity. It is possible that sufficient
telomerase activity is present in immortal CEF cells to
maintain telomere length, but that this level is not high
enough to be detected by the TRAP assay. It also is possi-
ble that telomere length is maintained in CEF cells
through alternative mechanisms, as has been proposed in
a number of human cells lines that do not display telom-
erase activity [54,55]. Although telomerase activity was
undetectable, mRNA expression of TRF2, which is
involved in the maintenance of telomeres, was elevated in
passage 95 SC-2 cells (data not shown) suggesting that
TRF2 may participate in the stabilization of telomere
length in SC-2 cells.
Conclusion
Unlike other studies that have introduced exogenous
genes into cells in attempt to achieve immortalization or
else have characterized a spontaneously immortalized cell
line after it had been established, the spontaneous
immortalization of the SC-2 cell line was analyzed as it
transitioned from a life-span extended population of cells
into a fully immortal cell line. Our results indicated that
an initial down-regulation of p53 allowed the SC-2 cells
to bypass senescence. The elevated levels of p53 mRNA in
passage 95 SC-2 cells were shown to be partially non-func-
tional using the luciferase reporter assay, and also verified
by the significantly down-regulated p21WAF1 expression
that was observed. In fact, it has been shown that the loss
of p21WAF1 allowed cells to bypass senescence in spite of
p16INK4a expression [56], which is what was observed in
the SC-2 cells. The inactivation of p53, and consequently
p21WAF1, likely contributed to the SC-2 cells becoming a
fully immortal cell line.
Methods
Cells and culture conditions
Primary and immortal CEF cells were grown in Dulbecco's
Modified Eagle Medium (DMEM) high glucose enriched
with 10% fetal calf serum (FCS), 1% penicillin-streptomy-
cin, and 2 mM L-glutamine. All cell culture reagents were
purchased from Invitrogen (Carlsbad, CA). The spontane-
ously immortalized DF-1 CEF cell line was derived from
East Lansing Line 0 (ev-0) leghorn layer embryos [Avian
Disease and Oncology Laboratory, East Lansing, MI)
[5,6,7,8]. The spontaneously immortalized SC-2 CEF cell
line was derived from SPAFAS eggs (specific pathogen free
avian supply, Charles River Laboratories, North Franklin,
CT). For the inhibition of translation studies, primary and
immortal cells were incubated in 10% FCS-DMEM sup-
plemented with 10 µg/ml of cycloheximide (CHX; Sigma,
St. Louis, MO) for 4 h.
Cell growth and cell cycle analysis
To determine growth rates, primary (passage 6 and 18)
and immortal (DF-1 and SC-2) CEF cells were plated at a
density of 3 × 105 cells/10 cm dish using culture condi-
tions as described above. At 80% confluency, cells were
trypsinized, counted, and the number of population dou-
blings per day (pd/d) calculated. Cell growth also was
determined by plating cells at a density of 1 × 105 cells/10
cm dish using conditions as described above, and count-
ing cells each day for up to 6 days to determine cell num-
bers. Cell cycle analysis was carried out using FACS of
propidium-iodide-stained cells and a Cell Quest software
program (Becton Dickinson, Franklin Lakes, NJ) as
described previously [57].
Cell line characterization
Karyotypic analysis of cells was conducted by the Veteri-
nary Diagnostic Laboratory at the University of Minne-
sota. The SC-2 cells were analyzed twice for reverse
transcriptase (RT) activity using the EnzCheck RT Assay kit
(Molecular Probes/Invitrogen Inc., Eugene, OR) accord-
ing to the manufacturer's instructions. Mycoplasma con-
tamination was analyzed using the Mycoplasma Plus™ kit
(Stratagene, La Jolla, CA) according to the manufacturer's
instructions.
RT-PCR analysis
For semi-quantitative RT-PCR, 3 µg of DNase I-treated
RNA was converted to cDNA using Superscript II reverse
transcriptase (Invitrogen, Carlsbad, CA) following the
manufacturer's instructions. A portion (1 µl) of the reverse
transcription reaction was used to amplify cDNA frag-
ments with chicken-specific primers (information reg ard-
ing primers and PCR conditions used in RT-PCR will be
provided upon request). All semi-quantitative cDNA frag-
ments were amplified using TaKaRa Ex Taq© (Intergen,
Burlington, MA). PCR products were verified to be in the
linear range and visualized by ethidium bromide staining.
Images were processed using the Eagle Eye II still video
system (Stratagene, La Jolla, CA). To validate the above
quantitation method, PCR products also were amplifiedBMC Cell Biology 2006, 7:27 http://www.biomedcentral.com/1471-2121/7/27
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for 15 cycles (undetectable by ethidium bromide stain-
ing) and detected by standard Southern blot hybridiza-
tion using their corresponding [α-32P]-labeled cDNA
probes prepared by RT-PCR (data not shown). A mini-
mum of three independent RT-PCR experiments were
analyzed using the NIH image software program and nor-
malized using the expression levels of GAPDH.
Analysis of p53 and p15INK4b proteins
Cell lysate protein (30 µg; determined using the Bio-Rad
protein reagent) was separated by SDS-PAGE with precast
4%-20% gradient gels (Bio-Rad, Hercules, CA). Gels were
electro-transferred to nitrocellulose paper, and proteins
were detected with antibodies specific for p53 (SC-99,
Santa Cruz Biotechnology, Santa Cruz, CA) and p15INK4b
(a gift from Gordon Peters), followed by horseradish per-
oxidase-labeled secondary antibody and either chemilu-
minescence or colorimetric detection systems.
p53 functional assay
A p53-Luciferase reporter plasmid was constructed in the
pGL3 Luciferase reporter vector (Promega, Madison, WI)
using double-stranded oligonucleotides corresponding to
tetramers of the p53 consensus binding sequence (5'-
AGGCATGCCT-3') as described previously [44]. Transient
transfection was carried out using electroporation (1100
µF, 275 V) as previously described [58]. For transfection,
20 µg of promoter reporter plasmids (p53-Luc) or 20 µg
of control reporter plasmids (Con-Luc) [44] were cotrans-
fected with 5 µg of pcDNA3.1-LacZ plasmid. Transfection
efficiency was normalized using PCR amplification of the
β-lactamase (LacZ) gene by PCR. Gel loading was normal-
ized using RT-PCR amplification of the GAPDH gene. Lev-
els of luciferase activity were determined using the
Luciferase Assay System (Promega) following the manu-
facturer's instructions.
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